SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-055527
Filing Date
2019-11-06
Accepted
2019-11-06 17:04:15
Documents
2
Period of Report
2019-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1625
2 POA DOCUMENT poa.txt EX-24.3_878487 3440
  Complete submission text file 0001209191-19-055527.txt   6522
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118
Business Address
Alam Kamran (Reporting) CIK: 0001793412 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36829 | Film No.: 191197130